Selective reporting biases in cancer prognostic factor studies

被引:184
作者
Kyzas, PA
Loizou, KT
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece
[2] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece
[3] Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Dept Med, Boston, MA 02111 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词
D O I
10.1093/jnci/dji184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Nonreported and selectively reported information and the use of different definitions may introduce biases in the literature of prognostic factors. We probed these biases in a meta-analysis of a prognostic factor for head and neck squamous cell cancer (HNSCC) mortality that has drawn wide attention-the status of the tumor suppressor protein TP53. Methods: We compared results of meta-analyses that included published data plus unpublished data retrieved from investigators; published data; and only published data indexed with "survival" or "mortality" in MEDLINE/EMBASE, with or without standardized definitions. We also evaluated whether previously published meta-analyses on mortality predictors for various malignancies addressed issues of retrieval and standardized information. All statistical tests were two-sided. Results: For the 18 studies with 1364 patients that included published and indexed data, we obtained a highly statistically significant association between TP53 status and mortality. When we used the definitions preferred by each publication, the association was stronger (risk ratio [RR] = 1.38, 95% confidence interval [CI] = 1.13 to 1.67; P =.001) than when we standardized definitions (RR = 1.27, 95% CI = 1.06 to 1.53; P =.011). The addition of 13 studies with 1028 subjects that included published but not indexed data reduced the observed association (RR = 1.23, 95% CI = 1.03 to 1.47; P =.02). Finally, when we obtained data from investigators (11 studies with 996 patients) and analyzed it with all other data, statistical significance was lost (RR = 1.16, 95% CI = 0.99 to 1.35; P =.06). Among 18 published meta-analyses of 37 cancer prognostic factors, 13 (72%) did not use standardized definitions and 16 (89%) did not retrieve additional information. Conclusions: Selective reporting may spuriously inflate the importance of postulated prognostic factors for various malignancies. We recommend that meta-analyses thereof should maximize retrieval of information and standardize definitions.
引用
收藏
页码:1043 / 1055
页数:13
相关论文
共 135 条
[21]   Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases [J].
de Vicente, JC ;
Gutiérrez, LMJ ;
Zapatero, AH ;
Forcelledo, MFF ;
Hernández-Vallejo, G ;
Arranz, JSL .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (01) :22-30
[22]   PUBLICATION BIAS AND CLINICAL-TRIALS [J].
DICKERSIN, K ;
CHAN, S ;
CHALMERS, TC ;
SACKS, HS ;
SMITH, H .
CONTROLLED CLINICAL TRIALS, 1987, 8 (04) :343-353
[23]  
Dunphy CH, 1997, ARCH OTOLARYNGOL, V123, P1223
[24]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[25]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[26]   TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer [J].
Erber, R ;
Conradt, C ;
Homann, N ;
Enders, C ;
Finckh, M ;
Dietz, A ;
Weidauer, H ;
Bosch, FX .
ONCOGENE, 1998, 16 (13) :1671-1679
[27]  
FRANK JL, 1994, CANCER-AM CANCER SOC, V73, P181, DOI 10.1002/1097-0142(19940101)73:1<181::AID-CNCR2820730131>3.0.CO
[28]  
2-3
[29]   Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma [J].
Friedman, M ;
Lim, JW ;
Manders, E ;
Schaffner, AD ;
Kirshenbaum, GL ;
Tanyeri, HM ;
Caldarelli, DD ;
Coon, JS .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (04) :280-285
[30]  
Fujieda S, 1999, INT J CANCER, V84, P315, DOI 10.1002/(SICI)1097-0215(19990621)84:3<315::AID-IJC20>3.3.CO